Outcome of a retrieval stent filter and 30mm balloon dilator for patients with Budd–Chiari syndrome and chronic inferior vena cava thrombosis: a prospective pilot study

Ding, Peng-Xu; Han, Xinwei; Wu, Gang; Li, Y.-D.; Shui, Shaofeng; Wang, Y.-L.

doi:10.1016/j.crad.2010.01.023

Cited by 15 publications

(5 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Catheter-direct thrombolysis was used for BCS patients with fresh thrombus in hepatic veins or IVC, [ 21 , 22 ] and retrieval stent placement was used in 2 cases to prevent pulmonary embolism and compress bolt in IVC. [ 23 – 25 ]…”

Section: Discussionmentioning

confidence: 99%

Excellent long-term outcomes of endovascular treatment in budd–chiari syndrome with hepatic veins involvement

Chen

Ding

et al. 2018

Medicine

View full text Add to dashboard Cite

This study aimed to evaluate the long-term efficacy and safety of percutaneous transhepatic balloon angioplasty (PTBA) and transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the treatment of Budd–Chiari syndrome (BCS) with hepatic veins involvement. Between June 2008 and August 2016, a total of 60 BCS patients with hepatic vein involvement in our department were enrolled in this study. Thirty-three cases underwent hepatic vein balloon angioplasty in PTBA Group and 27 cases underwent TIPSS. Data were retrospectively collected, and follow-up observations were performed. TIPSS Group showed significantly higher thrombotic/segmental obstruction and peripheral stenosis/obstruction compared with PTBA Group. The success rates were 93.9% and 100.0% in PTBA Group and TIPSS Group, respectively. The mean portal vein pressure decreased significantly after stenting. Except for 1 patient died from repeated hemorrhage, other sever complications had not been observed in both group. Twenty-six patients and 21 patients were clinically cured in PTBA Group and TIPSS Group, respectively. The primary patency rates were 89.7%, 79.3%, and 79.3% for short-term, mid-term and longterm in PTBA Group, which were significantly higher than TIPSS Group for long-term follow up. The second patency rates were 100.0%, 96.6% and 96.6% for short-term, mid-term and long-term in PTBA Group, which were similar to TIPSS Group (P = 1.0000). In conclusion, PTBA and TIPSS are safe and effective in the treatment of BCS with hepatic veins involvement, with an excellent long-term patency rate of hepatic vein and TIPSS shunt. TIPSS can be used to treat patients with all 3 hepatic veins lesion and failure PTBA.

show abstract

Section: Discussionmentioning

confidence: 99%

Excellent long-term outcomes of endovascular treatment in budd–chiari syndrome with hepatic veins involvement

Chen

Ding

et al. 2018

Medicine

View full text Add to dashboard Cite

show abstract

“…Treatment strategies are tailored to multiple patient and disease-specific factors [5] . Available options for treatment of BCS with HV and/or IVC involvement include medical management with anticoagulants and diuretics [2] ; endovascular management with balloon angioplasty, stenting, catheter-directed thrombolysis, transjugular intrahepatic portosystemic shunting, and retrieval stent filter placement [1] , [3] , [8] , [9] , [12] , [13] , [14] , [15] ; and surgical management with surgical portosystemic shunting, orthotopic liver transplantation, and surgical membranectomy [1] , [2] , [16] .…”

Section: Discussionmentioning

confidence: 99%

Percutaneous sharp recanalization of a membranous IVC occlusion with an occlusion balloon as a needle target

Rivers-Bowerman

Lightfoot

Meagher

et al. 2017

Radiology Case Reports

View full text Add to dashboard Cite

A 50-year-old male with right upper quadrant symptoms and hepatic dysfunction was found to have multiple dilated hepatic veins (HVs) with intrahepatic collateralization and membranous occlusion of the intrahepatic inferior vena cava (IVC) consistent with primary Budd–Chiari syndrome. Venacavograms depicted drainage of the intrahepatic collaterals through a left-sided HV entering the IVC above the level of the occlusion. Sharp recanalization of the membranous IVC occlusion was performed with an occlusion balloon as a needle target under echocardiographic monitoring followed by balloon angioplasty with restoration of IVC patency. Clinical, laboratory, and venographic procedural success has been demonstrated to 9 months with minimal residual stenosis.

show abstract

“…4,5,10,11 Due to the obstruction of the proximal IVC, the blood flow in the IVC is slow, turbulent, or reversed; these conditions in addition to the hypercoagulable state of the blood facilitate thrombus formation. Although several treatment methods are available for IVC obstruction in BCS, such as transjugular intrahepatic portosystemic shunts, 9,12,13 surgical shunts, balloon angioplasty, metallic stents, [3][4][5] and retrievable stent filters, 14,15 these are usually complicated, expensive, and carry the risk of complications or bleeding.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of Thrombolysis With and Without Predilation of the Inferior Vena Cava (IVC) in Patients With Budd–Chiari Syndrome With Old IVC Thrombosis

Ren

Huang

Ding

et al. 2013

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

Outcome of a retrieval stent filter and 30mm balloon dilator for patients with Budd–Chiari syndrome and chronic inferior vena cava thrombosis: a prospective pilot study

Cited by 15 publications

References 13 publications

Excellent long-term outcomes of endovascular treatment in budd–chiari syndrome with hepatic veins involvement

Excellent long-term outcomes of endovascular treatment in budd–chiari syndrome with hepatic veins involvement

Percutaneous sharp recanalization of a membranous IVC occlusion with an occlusion balloon as a needle target

Outcomes of Thrombolysis With and Without Predilation of the Inferior Vena Cava (IVC) in Patients With Budd–Chiari Syndrome With Old IVC Thrombosis

Contact Info

Product

Resources

About